Spots Global Cancer Trial Database for multiple myeloma, refractory to standard treatment
Every month we try and update this database with for multiple myeloma, refractory to standard treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Relapsed or Refractory Multiple Myeloma (BMT-03) | NCT02043847 | Multiple Myelom... Multiple Myelom... | Total Marrow Ir... Melphalan Filgrastim (G-C... Autologous tran... Total Marrow Ir... Melphalan Filgrastim (G-C... Autologous tran... Total Marrow Ir... Melphalan Filgrastim (G-C... Autologous tran... | 18 Years - 75 Years | University of Illinois at Chicago |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
